Scholar Commonsmetadata only
State Prior Authorization Prohibitions and Buprenorphine Retention Among Privately Insured Patients
prior authorization prohibitions, buprenorphine retention, privately insured patients, opioid use disorder, medication for opioid use disorder, moud, insurance policy, treatment retention
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 331557
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.